RP3128

RP3128 · Rhizen Pharmaceuticals SA

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RP3128, covering 2019-10-04 to 2019-10-04. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability and Pharmacokinetics of Oral Doses of RP3128 of Rhizen Pharmaceuticals [Phase 1, Phase 2]